The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
Open accessAbstract
Oxidative stress and enhanced lipid peroxidation are linked to many chronic inflammatory diseases, including age-related macular degeneration (AMD). AMD is the leading cause of blindness in Western societies, but its aetiology remains largely unknown. Malondialdehyde (MDA) is a common lipid peroxidation product that accumulates in many pathophysiological processes, including AMD. Here we identify complement factor H (CFH) as a major MDA-binding protein that can block both the uptake of MDA-modified proteins by macrophages and MDA-induced proinflammatory effects in vivo in mice. The CFH polymorphism H402, which is strongly associated with AMD, markedly reduces the ability of CFH to bind MDA, indicating a causal link to disease aetiology. Our findings provide important mechanistic insights into innate immune responses to oxidative stress, which may be exploited in the prevention of and therapy for AMD and other chronic inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Oxidative stress adducts and components of the complement system have been found to accumulate in drusen and sub-RPE deposits of patients with AMD (Weismann et al., 2011; Shaw et al., 2012), and mice with mutations making them prone to oxidative stress or dysregulation of the complement pathway have been presented as models of AMD (Imamura et al., 2006; Justilien et al., 2007; Hollyfield et al., 2”
From Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis (2015) · cites this paper as Weismann et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C. D., & Haslett, C. (2002) · Nature reviews. Immunology · doi:10.1038/nri957 · Cited by 1,574
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature reviews. Immunology · doi:10.1038/nri2620 · Cited by 1,268
Age-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787
Age-related Macular Degeneration Histopathologic Studies
Green, W. R., & Enger, C. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31466-1 · Cited by 757
Cited by
Sorted by citations
Items 101–200 of 533
The multifaceted impact of complement on atherosclerosis
Kiss, M. G., & Binder, C. J. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.014 · Cited by 97
Developments in anti-complement therapy; from disease to clinical trial
Harris, C. L., Pouw, R. B., Kavanagh, D., Sun, R., & Ricklin, D. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.008 · Cited by 93
The eye: A window to the soul of the immune system
Perez, V. L., Saeed, A. M., Tan, Y. C. R. S., Urbieta, M., & Cruz‐Guilloty, F. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.011 · Cited by 93
“CFH is centrally important in AMD and a particular CFH polymorphism (yielding a missense mutation [Y402H]) is highly associated with the AMD disease state [36e38].”
BackgroundInfluentialMettu, P. S., Wielgus, A. R., Ong, S. S. Y., & Cousins, S. W. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.006 · Cited by 92
Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development
Mushenkova, N. V., Bezsonov, E. E., Orekhova, V. A., Попкова, Т. В., Starodubova, A. V., & Orekhov, A. N. (2021) · Biomedicines · doi:10.3390/biomedicines9080915 · Cited by 98
“CFH is the major inhibitor of the alternative pathway of complement activation that was recently shown to bind to and prevent the proinflammatory effects of MDA epitopes [70].”
BackgroundLeibundgut, G., Witztum, J. L., & Tsimikas, S. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.02.005 · Cited by 88
Bretscher, P., Egger, J., Shamshiev, A. T., Trötzmüller, M., Köfeler, H. C., Carreira, E. M., Köpf, M., & Freigang, S. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404702 · Cited by 88
“Keywords inflammation; isoprostanes; lung injury; Nrf2; oxidized phospholipids Subject Categories Immunology; Pharmacology & Drug Discovery DOI 10.15252/emmm.201404702 | Received 1 October 2014 | Revised 15 February 2015 | Accepted 16 February 2015 | Published online 13 March 2015 EMBO Mol Med (2015) 7: 593–607”
InfluentialYang, T., Peleli, M., Zollbrecht, C., Giulietti, A., Terrando, N., Lundberg, J. O., Weitzberg, E., & Carlström, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.016 · Cited by 88
Ansari, M., McKeigue, P., Skerka, C., Hayward, C., Rudan, I., Vitart, V., Polašek, O., Armbrecht, A.-M., Yates, J. R. W., Vatavuk, Z., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt336 · Cited by 90
Nutritional modulation of age-related macular degeneration
Weikel, K., Chiu, C., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.005 · Cited by 89
“A recent report indicates that wild type CFH is required to remove lipid oxidation products (Weismann et al., 2011).”
BackgroundComplement therapy in atypical haemolytic uraemic syndrome (aHUS)
Wong, E. K. S., Goodship, T. H. J., & Kavanagh, D. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.224 · Cited by 86
“Additionally CFH also binds to the lipid peroxidation roductmalondialdehyde (Weismann et al., 2011), the acute phase roteins, C-reactive protein (Hakobyan et al.”
BackgroundQiu, W., Chen, X., Tian, Y., Wu, D., Du, M., & Wang, S. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110881 · Cited by 89
Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration
Ferrington, D. A., Kapphahn, R. J., Leary, M. M., Atilano, S. R., Terluk, M. R., Karunadharma, P., Chen, G. K.-J., Ratnapriya, R., Swaroop, A., Montezuma, S. R., et al. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.01.018 · Cited by 85
Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis
Jiang, M., Esteve-Rudd, J., Lopes, V. S., Diemer, T., Lillo, C., Rump, A., & Williams, D. S. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201410112 · Cited by 85
“Oxidative stress adducts and components of the complement system have been found to accumulate in drusen and sub-RPE deposits of patients with AMD (Weismann et al., 2011; Shaw et al., 2012), and mice with mutations making them prone to oxidative stress or dysregulation of the complement pathway have been presented as…”
BackgroundKiss, M. G., Papac-Miličević, N., Porsch, F., Tsiantoulas, D., Hendrikx, T., Takaoka, M., Dinh, H. Q., Narzt, M., Göderle, L., Ozsvár-Kozma, M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.026 · Cited by 87
Cao, S., Ko, A., Partanen, M., Pakzad-Vaezi, K. L., Merkur, A. B., Albiani, D. A., Kirker, A. W., Wang, A., Cui, J. Z., Forooghian, F., et al. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.08.003 · Cited by 89
Deng, J., Fu, D., Hu, W., Lu, X., Wu, Y., & Bryan, H. M. (2020) · Bioresource Technology · doi:10.1016/j.biortech.2020.122963 · Cited by 84
Beneficial effects of noni (Morinda citrifolia L.) juice on livers of high-fat dietary hamsters
Lin, Y., Chang, Y., Yang, D., Tzang, B., & Chen, Y. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.02.035 · Cited by 87
The regulation of inflammation by oxidized phospholipids
Freigang, S. (2016) · European Journal of Immunology · doi:10.1002/eji.201545676 · Cited by 86
Zhang, F. J., Weng, X. G., Wang, J. F., Zhou, D., Zhang, W., Zhai, C., Hou, Y., & Zhu, Y. H. (2014) · Journal of Animal Science · doi:10.2527/jas.2013-6932 · Cited by 83
Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment
Mehrzadi, S., Hemati, K., Reiter, R. J., & Hosseinzadeh, A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737015 · Cited by 82
The Factor H protein family: The switchers of the complement alternative pathway
Lucientes, L., Márquez‐Tirado, B., & de Jorge, E. G. (2022) · Immunological Reviews · doi:10.1111/imr.13166 · Cited by 89
AMD and the alternative complement pathway: genetics and functional implications
Tan, P. L., Rickman, C. B., & Katsanis, N. (2016) · Human Genomics · doi:10.1186/s40246-016-0079-x · Cited by 79
“Additionally, one byproduct of lipid peroxidation product is malondialdehyde (MDA), a marker for oxidative stress that contributes to RPE dysfunction [94] and a binding partner to CFH, allowing for an endogenous antiinflammatory mediated response to this pro-inflammatory byproduct [95].”
BackgroundYe, F., Kaneko, H., Hayashi, Y., Takayama, K., Hwang, S.-J., Nishizawa, Y., Kimoto, R., Nagasaka, Y., Tsunekawa, T., Matsuura, T., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.027 · Cited by 79
A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy
Huang, L., Zhang, H., Cheng, C., Wen, F., Tam, P. O. S., Zhao, P., Chen, H., Li, Z., Chen, L., Tai, Z., et al. (2016) · Nature Genetics · doi:10.1038/ng.3546 · Cited by 77
Age-related macular degeneration: Complement in action
Campagne, M. V. L., Strauss, E. C., & Yaspan, B. L. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.11.007 · Cited by 76
Health Risks of Food Oxidation
Estévez, M., Li, Z., Soladoye, O. P., & Van-Hecke, T. (2017) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2016.12.005 · Cited by 75
Lashkari, S., Habibian, M., & Jensen, S. K. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1310-5 · Cited by 73
“Oxidative stress reflects cell damage or tissue inflammation resulting from an imbalance between an excessive generation of free radicals and reactive oxygen species and insufficient antioxidant defense mechanisms [103, 104].”
BackgroundLoss of Complement Factor H impairs antioxidant capacity and energy metabolism of human RPE cells
Armento, A., Honisch, S., Panagiotakopoulou, V., Sonntag, I., Jacob, A., Bolz, S., Kilger, E., Deleidi, M., Clark, S. J., & Ueffing, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67292-z · Cited by 75
B cell subsets in atherosclerosis
Perry, H. M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00373 · Cited by 73
“As such, identification and utilization of surrogate markers of atherosclerosis-based clinical events is essential (Choi et al., 2008; Fraley et al., 2009; Weismann et al., 2011; Purushothaman et al., 2012).”
BackgroundIrmscher, S., Brix, S. R., Zipfel, S. L. H., Halder, L. D., Mutlutürk, S., Wulf, S., Girdauskas, E., Reichenspurner, H. C., Stahl, R. A. K., Jungnickel, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10766-0 · Cited by 76
Implications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
Cuticular drusen: Stars in the sky
Boon, C. J. F., van de Ven, J. P. H., Hoyng, C. B., den Hollander, A. I., & Klevering, B. J. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.08.003 · Cited by 71
Evaluation of 12 Myopia-Associated Genes in Chinese Patients With High Myopia
Li, J., Jiang, D., Xiao, X., Li, S., Jia, X., Sun, W., Guo, X., & Zhang, Q. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14880 · Cited by 74
Marangoni, D., Falsini, B., Piccardi, M., Ambrosio, L., Minnella, A. M., Savastano, M. C., Bisti, S., Maccarone, R., Fadda, A., Mello, E., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-228 · Cited by 71
“[25] indicating that CFH could act as a protective factor against retinal oxidative stress.”
BackgroundPhyscomitrella patens, a versatile synthetic biology chassis
Ralf Reski, A., Bae, H., & Simonsen, H. T. (2018) · Plant Cell Reports · doi:10.1007/s00299-018-2293-6 · Cited by 70
Mohammadi, G., Karimi, A. A., Hafezieh, M., Dawood, M. A. O., & Abo‐Al‐Ela, H. G. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.12.042 · Cited by 70
Li, J.-F., Dai, X., Zhang, W., Sun, S., Zeng, Y., Zhao, G., Kou, Z., Guo, Y., Yu, H., Du, L., et al. (2015) · mBio · doi:10.1128/mbio.02459-14 · Cited by 71
“Constitutive high expression of CFH has been detected in the eye, and a CFH polymorphism is strongly associated with age-related macular degeneration (35); furthermore, CFH protects the eyes through recruiting to the surface of apoptotic cells, where it neutralizes the proinflammatory properties of these cells and hal…”
BackgroundGenetics and genetic testing for age-related macular degeneration
Warwick, A., & Lotery, A. (2018) · Eye · doi:10.1038/eye.2017.245 · Cited by 67
Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice
Busch, C. J., Hendrikx, T., Weismann, D., Jäckel, S., Walenbergh, S. M. A., Rendeiro, A. F., Weißer, J., Puhm, F., Hladik, A., Göderle, L., et al. (2016) · Hepatology · doi:10.1002/hep.28970 · Cited by 69
Lin, L., Yang, K., Zheng, L. P., Zhao, M., Sun, W., Zhu, Q., & Liu, S. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.05.033 · Cited by 69
Camelo, S. (2014) · Autoimmune Diseases · doi:10.1155/2014/532487 · Cited by 72
“Proteins modified with aldehydic adducts (MDA, 4-HNE) or CEP adducts become more immunogenic [6, 99–101].”
BackgroundHerbert, A. P., Makou, E., Chen, Z. A., Kerr, H., Richards, A., Rappsilber, J., & Barlow, P. N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501388 · Cited by 68
“11) as do oxidation-specific epitopes used for recruiting FH to damaged cells (53).”
BackgroundCoughlin, B., Schnabolk, G., Joseph, K., Raikwar, H., Kunchithapautham, K., Johnson, K., Moore, K., Wang, Y., & Rohrer, B. (2016) · Scientific Reports · doi:10.1038/srep23794 · Cited by 65
Hebecker, M., Alba‐Domínguez, M., Roumenina, L. T., Reuter, S., Hyvärinen, S., Dragon‐Durey, M., Jokiranta, T. S., Sánchez‐Corral, P., & Józsi, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300269 · Cited by 67
“Recently, MDA epitopes formed during oxidative damage were also shown to bind domains 19–20 of FH (44).”
BackgroundInfluentialProtective responses to sublytic complement in the retinal pigment epithelium
Tan, L. X., Toops, K. A., & Lakkaraju, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523061113 · Cited by 66
“as malondialdehyde activate complement (18); subretinal drusen from AMD patients have complement components (16); and retinal detachment down-regulates CD59, leading to MAC deposition in the photoreceptor-RPE region (19).”
BackgroundToma, C., Cillà, S. D., Palumbo, A., Garhwal, D. P., & Grossini, E. (2021) · Antioxidants · doi:10.3390/antiox10050653 · Cited by 67
Cruz‐Guilloty, F., Saeed, A. M., Duffort, S., Cano, M., Ebrahimi, K. B., Ballmick, A., Tan, Y., Wang, H., Laird, J. M., Salomon, R. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088201 · Cited by 68
“Because oxidized phospholipids and their resulting protein modifications have been shown to activate macrophages [29,43], we tested whether CEP has a direct effect on macrophage activation using an in vitro system.”
BackgroundJoseph, K., Kulik, L. N., Coughlin, B. A., Kunchithapautham, K., Bandyopadhyay, M., Thiel, S., Thielens, N. M., Holers, V. M., & Rohrer, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421891 · Cited by 67
“Identification of Roles for IgM-C2 in Vivo—MDA neoepitopes have been demonstrated in mouse CNV lesions by immunohistochemistry (21), and reactive oxygen species and superoxide radicals have been visualized in both the CNV lesion and the surrounding area (18).”
BackgroundResultInfluentialHtrA1 is induced by oxidative stress and enhances cell senescence through p38 MAPK pathway
Supanji, S., Shimomachi, M., Hasan, M. Z., Kawaichi, M., & Oka, C. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.04.013 · Cited by 67
“Two recent reports have shown that CFH bindsmalondialdehyde (MDA), a product of lipid peroxidation under oxidative stress (Shaw et al., 2012; Weismann et al., 2011).”
BackgroundZając-Pytrus, H. M., Pilecka, A., Turno‐Kręcicka, A., Adamiec-Mroczek, J., & Misiuk‐Hojło, M. (2015) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/27093 · Cited by 65
Dasari, P., Koleci, N., Shopova, I. A., Wartenberg, D., Beyersdorf, N., Dietrich, S., Sahagún-Ruiz, A., Figge, M. T., Skerka, C., Brakhage, A. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02573 · Cited by 65
“, via glycosaminoglycans (GAGs), or modified surface constituents, like Malondialdehyde or phosphatidyl choline (49).”
BackgroundMaurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“The AMD-associated CFH variant H402 strongly reduces its binding affinity to malondialdehyde, suggesting a mechanistic link (Weismann et al., 2011).”
Formononetin protects TBI rats against neurological lesions and the underlying mechanism
Li, Z., Dong, X., Zhang, J., Zeng, G., Zhao, H., Liu, Y., Qiu, R., Mo, L., & Ye, Y. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.027 · Cited by 62
“Malondialdehyde (MDA) generation induced by lipotoxicity stress originates from the ROSmediated polyunsaturated lipid degradation [28–30].”
BackgroundLangford-Smith, A., Keenan, T. D. L., Clark, S. J., Bishop, P. N., & Day, A. J. (2013) · Journal of Innate Immunity · doi:10.1159/000356513 · Cited by 64
Wang, C., Turunen, S. P., Kummu, O., Veneskoski, M., Lehtimäki, J. I., Nissinen, A. E. T., & Hörkkö, S. (2013) · International Immunology · doi:10.1093/intimm/dxt022 · Cited by 61
Redox-derived damage-associated molecular patterns: Ligand function of lipid peroxidation adducts
Uchida, K. (2013) · Redox Biology · doi:10.1016/j.redox.2012.12.005 · Cited by 61
“[14] recently identified complement factor H as a major regulatory protein that specifically binds MDA-modified proteins.”
BackgroundLuo, S., Hoffmann, R., Skerka, C., & Zipfel, P. F. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis718 · Cited by 62
“dation product that accumulates in many pathophysiological processes [46].”
BackgroundLorés‐Motta, L., van Beek, A. E., Willems, E., Zandstra, J., van Mierlo, G. J., Einhaus, A., Mary, J.-L., Stucki, C., Bakker, B., Hoyng, C. B., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.06.002 · Cited by 62
Different Therapeutic Approaches for Dry and Wet AMD
Marchesi, N., Capierri, M., Pascale, A., & Barbieri, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313053 · Cited by 66
“CFH plays a key role in the regulation of complement activation and represents a defense against lipid peroxidation and oxidative stress [22–25].”
Oxidative Stress and Neurobiology of Demyelination
Ljubisavljević, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9041-x · Cited by 60
“The probable mechanism in the basis of this effect is the takeover of molecules modified by MDA activity by phagocytic cells, which prevents the loss of immunotolerance and, in that way, the adverse effects in the nervous tissue which could be initiated [107].”
BackgroundOf mice and men: The factor H protein family and complement regulation
Pouw, R. B., Vredevoogd, D. W., Kuijpers, T. W., & Wouters, D. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.011 · Cited by 61
Sánchez‐Corral, P., Pouw, R. B., López‐Trascasa, M., & Józsi, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01607 · Cited by 58
“FH was shown to bind to MDA/ MAA epitopes and inhibit complement activation and the proinflammatory effects of such MDA/MAA epitopes (99).”
BackgroundBorras, C., Canonica, J., Jorieux, S., Abache, T., Sanharawi, M. E., Klein, C., Delaunay, K., Jonet, L., Salvodelli, M., Naud, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50420-9 · Cited by 58
Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration
Klein, R., Myers, C. E., Meuer, S. M., Gangnon, R. E., Sivakumaran, T. A., Iyengar, S. K., Lee, K. E., & Klein, B. E. K. (2012) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.713 · Cited by 59
“The CFH gene also affects the metabolism of lipids, such as malondialdehyde, thataccumulate inresponse tooxidative stressandare thought tocontribute toRPEcelldeath.(67) The role of ARMS2 is also uncertain.”
Complement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.007 · Cited by 59
“Interestingly, the 402H polymorphism also reduced the ability of CFH to bind MDA.”
BackgroundInfluentialSenders, M. L., Que, X., Cho, Y. S., Yeang, C., Groenen, H., Fay, F., Calcagno, C., Meerwaldt, A. E., Green, S., Miu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.036 · Cited by 58
Kim, S., Kambhampati, S. P., Bhutto, I. A., McLeod, D. S., Lutty, G. A., & Kannan, R. M. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108391 · Cited by 60
Candida and Complement: New Aspects in an Old Battle
Harpf, V., Rambach, G., Würzner, R., Lass‐Flörl, C., & Speth, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01471 · Cited by 55
Wang, Y., Liu, Y., Liu, Y., Zhong, J., Wang, J., Sun, L., Yu, L., Wang, Y., Li, Q., Jin, W., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122028 · Cited by 56
Oxidative stress in dry age-related macular degeneration and exfoliation syndrome
Chiras, D., Kitsos, G., Petersen, M. B., Skalidakis, I., & Κroupis, C. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.968703 · Cited by 56
Proteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
Skeie, J. M., & Mahajan, V. B. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2065 · Cited by 56
Ryu, S. K., Mallat, Z., Bénessiano, J., Tedgui, A., OLSSON, A. G., Bao, W., Schwartz, G. G., Tsimikas, S., & for the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Trial Investigators (2012) · Circulation · doi:10.1161/circulationaha.111.063487 · Cited by 56
Romero‐Vázquez, S., Llorens, V., Soler-Boronat, A., Figueras‐Roca, M., Adán, A., & Molins, B. (2021) · Biomedicines · doi:10.3390/biomedicines9070763 · Cited by 56
“Indeed, MDA can cause RPE damage and MDA-modified proteins are known to induce inflammatory responses and are recognized by innate immunity [51,52].”
BackgroundInfluentialOlivar, R., Luque, A., Cárdenas-Brito, S., Naranjo‐Gómez, M., Blom, A. M., Borràs, F. E., de Córdoba, S. R., Zipfel, P. F., & Aran, J. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500455 · Cited by 55
“inflammation (14), protection from oxidative stress (15), modulation of platelet structure and function (16), anticoagulation (17), and regulation of cellular immune-inflammatory responses by in-”
BackgroundLi, C., Wang, L., Zhang, J., Huang, M. N., Wong, F., Liu, X., Liu, F., Cui, X., Yang, G., Chen, J., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.009 · Cited by 53
Gonen, A., Hansen, L. F., Turner, W. W., Montano, E. N., Que, X., Rafia, A., Chou, M.-Y., Wiesner, P., Tsiantoulas, D., Corr, M., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053256 · Cited by 53
Chu, Q., Jia, R., Chen, M., Li, Y., Yu, X., Wang, Y., Chen, W., Ye, X., Liu, Y., Jiang, Y., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.039 · Cited by 53
Woodell, A. S., Coughlin, B. A., Kunchithapautham, K., Casey, S. E., Williamson, T., Ferrell, W. D., Atkinson, C., Jones, B. W., & Rohrer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067894 · Cited by 52
“Likewise, the Y402H allele, which binds less effectively to malondialdehyde epitopes and oxidized phospholipids (generated by oxidative stress [92,93]), is correlated with the size of peripheral drusen and increases in reticular pigment [14,15].”
BackgroundInduction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
Švajger, U., & Rožman, P. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02482 · Cited by 52
“Besides the direct negative regulation of complement activation, FH also interacts with other endogenous ligands or receptors which extends its activity to protection from oxidative stress (99), modulation of platelet function (100), and regulation of immunity via interaction with several cells of the immune system (1…”
BackgroundComplement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
Segers, F. M., Verdam, F. J., de Jonge, C., Boonen, B., Driessen, A., Shiri-Sverdlov, R., Bouvy, N. D., Greve, J. W. M., Buurman, W. A., & Rensen, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110053 · Cited by 50
“Low factor H expression may also play a role in the detrimental effects of lipid peroxidation products in NASH [12,23], since factor H was recently shown to recognize epitopes associated with oxidative stress and to mediate their neutralization [24].”
BackgroundThe hijackers guide to escaping complement: Lessons learned from pathogens
Ermert, D., Ram, S., & Laabei, M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.018 · Cited by 51
Canonical and non-canonical roles of complement in atherosclerosis
Maffia, P., Mauro, C., Case, A. G., & Kemper, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01016-y · Cited by 53
“The classical pathway is initiated by binding of the C1q subunit within the C1 complex to immune complexes or DAMPs exposed by stressed or dying cells, which then induces the activation of C4 and C2 into C4a and C4b and C2a and C2b, respectively.”
InfluentialPujol-Lereis, L. M., Schäfer, N., Kuhn, L. B., Rohrer, B., & Pauly, D. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_13 · Cited by 49
Biswal, M. R., Justis, B. D., Han, P., Li, H., Gierhart, D. L., Dorey, C. K., & Lewin, A. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203816 · Cited by 50
Bora, N. S., Matta, B., Lyzogubov, V. V., & Bora, P. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.012 · Cited by 49
Ricklin, D. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.016 · Cited by 49
Suppression of Light-Induced Oxidative Stress in the Retina by Mitochondria-Targeted Antioxidant
Baksheeva, V. E., Tiulina, V. V., Tikhomirova, N. K., Gancharova, O. S., Komarov, S. V., Philippov, P. P., Zamyatnin, A. A., Senin, I. I., & Zernii, E. Y. (2018) · Antioxidants · doi:10.3390/antiox8010003 · Cited by 47
“First, the illuminated retina exhibited increased lipid peroxidation manifesting in elevation of MDA content (Figure 2).”
BackgroundInfluentialViola, T. W., Orso, R., Florian, L. F., Garcia, M. G., Gomes, M. G. S., Mardini, E. M., Niederauer, J. P. O., Zaparte, A., & Grassi‐Oliveira, R. (2022) · Addiction Biology · doi:10.1111/adb.13254 · Cited by 50
Clark, S. J., & Bishop, P. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm4010018 · Cited by 46
“Age-dependent changes in the levels of metal ions [47] and products of oxidative stress [48,49] have been suggested as possible contributors to this phenomenon.”
BackgroundHigh-density lipoproteins are a potential therapeutic target for age-related macular degeneration
Kelly, U., Grigsby, D., Cady, M. A., Landowski, M., Skiba, N. P., Liu, J., Remaley, A. T., Klingeborn, M., & Rickman, C. B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012305 · Cited by 46
“The Y402H polymorphism decreases the binding of FH to heparin (22,26), M6 protein of Streptococcus pyogenes (26,27), CRP (22,26-28), Bruch’s membrane (BrM) (29), malondialdehyde (MDA) epitopes (30) and oxidized phospholipids (31).”
BackgroundWang, M., Zhang, X., Jia, W., Zhang, C., Boczek, T., Harding, M. H., Liu, Y., Li, M., Zhang, S., Lei, S., et al. (2021) · Seizure · doi:10.1016/j.seizure.2021.07.001 · Cited by 46
Yoshida, H., Shoda, T., Yanai, H., Ikewaki, K., Kurata, H., Ito, K., Furutani, N., Tada, N., Witztum, J. L., & Tsimikas, S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.069 · Cited by 46
Silva, A. S., Teixeira, A., Bavia, L., Lin, F. L. H., Velletri, R., Belfort, R., & Isaac, L. (2012) · Europe PMC (PubMed Central) · Cited by 46
Thioredoxin rod-derived cone viability factor protects against photooxidative retinal damage
Elachouri, G., Lee-Rivera, I., Clérin, E., Argentini, M., Fridlich, R., Blond, F., Ferracane, V., Yang, Y., Raffelsberger, W., Wan, J., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.003 · Cited by 46
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
“A lack of functional FH may also impair the clearance of lipid peroxidation products [131], leading to oxidative stress [139].”
BackgroundThe complement system: a novel therapeutic target for age-related macular degeneration
Shughoury, A., Sevgi, D. D., & Ciulla, T. A. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2257604 · Cited by 45
“CFH may also independently act as a protective antioxidant in the RPE [83–85] and participate in lipid metabolism [85,86].”
BackgroundA Family Affair: Addressing the Challenges of Factor H and the Related Proteins
Poppelaars, F., de Jorge, E. G., Jongerius, I., Baeumner, A. J., Steiner, M., Józsi, M., Toonen, E. J. M., & Pauly, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660194 · Cited by 45
Radu, R. A., Hu, J., Jiang, Z., & Bok, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548669 · Cited by 44
“Y402H-substituted CFH has been shown recently to bind malondialdehyde with greatly reduced affinity (13).”
BackgroundThe Landscape of Smart Biomaterial‐Based Hydrogen Therapy
Xu, M., Wu, G., You, Q., & Chen, X. S. (2024) · Advanced Science · doi:10.1002/advs.202401310 · Cited by 43
Metadata
- Authors
- Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., Superti-Furga, G., Handa, J. T., Zipfel, P. F., Witztum, J. L., & Binder, C. J.
- Affiliations
- Austrian Academy of Sciences (AT)
- Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) (DE)
- Johns Hopkins University (US)
- University of Oxford (GB)
- Octapharma (Austria) (AT)
- University of California San Diego (US)
- Corresponding author
- Binder, Christoph J.
- ORCID
- Venue
- Nature
- Published
- 2011-10
- Volume
- 478
- Issue
- 7367
- Pages
- 76-81
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4826616
- OpenAlex
- W2062097745
- Cited by
- 533
- References
- 42
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 25 · 2023: 30 · 2022: 29 · 2021: 42 · 2020: 36 · 2019: 29 · 2018: 33 · 2017: 31 · 2016: 39 · 2015: 42 · 2014: 44 · 2013: 66 · 2012: 44
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01-HL086599, HL-088093, P01HL088093)
- National Eye Institute (EY14005, R01EY014005, EY019044, R01EY019904)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- complement factor H, malondialdehyde, lipid peroxidation, oxidative stress, age-related macular degeneration, macrophage uptake, pro-inflammatory effects, innate immunity, chronic inflammation, retina
- MeSH terms
- Animals, Epitopes, Binding Sites, Complement System Proteins, Complement Inactivator Proteins, Enzyme-Linked Immunosorbent Assay, Female, Humans, Inflammation, Macular Degeneration, Male, Malondialdehyde, Mice, Inbred C57BL, Mutation, Necrosis, Protein Binding, Retina, Lipid Peroxidation, Apoptosis, Complement Factor H, Protein Structure, Tertiary, Macrophages, Peritoneal, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review